Request for Information: Rigor, Reproducibility and Statistical Power in Mental Health Research
Notice NOT-MH-17-036 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2017 Category: Research Source Type: funding
Notice of Frequently Asked Questions for RFA-HL-18-008 "Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34)"
Notice NOT-HL-17-526 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2017 Category: Research Source Type: funding
Notice of Frequently Asked Questions for PAR-17-294 "Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01)"
Notice NOT-HL-17-525 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2017 Category: Research Source Type: funding
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01)
Funding Opportunity PAR-17-294 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide access to a consultative resource for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. The FOA will support the development of feasible and well-designed clinical trials utilizing consultative services p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 19, 2017 Category: Research Source Type: funding
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01)
Funding Opportunity RFA-HL-18-009 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide access to a consultative resource for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. The FOA will support the development of feasible and well-designed clinical trials utilizing consultative service...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 17, 2017 Category: Research Source Type: funding
